MedTrace Logo

EPC Performance Investigation for StereoElectroEncephaloGraphy

NCT05223985 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2024-08-05

No results posted yet for this study

Summary

The objective of this multicentre study is to collect preoperative, intra operative, early, short, intermediate and mid-term(one years) on the related clinical complications and functional outcomes of market-approved Alcis products to demonstrate safety and performance of these devices in a real-world setting.

Conditions

Interventions

DEVICE

Depth Coagulation Electrode

SEEG and thermocoagulation

Sponsors & Collaborators

  • Alcis

    lead INDUSTRY

Eligibility

Min Age
18 Months
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-29
Primary Completion
2024-12-30
Completion
2024-12-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05223985 on ClinicalTrials.gov